6-Morpholinonicotinic Acid → HCID 59401813, compound
Reaction equation
[CH3:1][C:2]1[CH:7]=[C:6]([N:8]2[CH2:12][CH2:11][CH:10]([N:13]3[CH2:17][CH2:16][CH2:15][CH:14]3[CH3:18])[CH2:9]2)[CH:5]=[CH:4][C:3]=1[NH2:19].[N:20]1([C:26]2[CH:34]=[CH:33][C:29]([C:30](O)=[O:31])=[CH:28][N:27]=2)[CH2:25][CH2:24][O:23][CH2:22][CH2:21]1>>[CH3:1][C:2]1[CH:7]=[C:6]([N:8]2[CH2:12][CH2:11][CH:10]([N:13]3[CH2:17][CH2:16][CH2:15][CH:14]3[CH3:18])[CH2:9]2)[CH:5]=[CH:4][C:3]=1[NH:19][C:30](=[O:31])[C:29]1[CH:33]=[CH:34][C:26]([N:20]2[CH2:21][CH2:22][O:23][CH2:24][CH2:25]2)=[N:27][CH:28]=1Participants
3
Procedure
The title compound was prepared in a manner substantially the same as example 1 by coupling 2-methyl-4-(2-methyl-[1,3′]bipyrrolidinyl-1′-yl)-phenylamine with 6-morpholin-4-yl-nicotinic acid. MS: 450.5 (M+H).
Sources & evidence
- ORD record
- ord-4319a481e81642d69834b5e8a652db60
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08618159B2
Reaction notes
Loading…